Are you suffering from
Achilles Pain?
We are conducting a new clinical study testing a non-compressive, drug-free therapy for Achilles tendinopathy — a common and stubborn injury.
Help us shape the future of tendon care without the need for surgery, injections, or medication.
Study sponsor: Incrediwear.
Participant Benefits
Clinical Excellence
& Patient Advantages
*Study approval: Health Research Authority (HRA), REC reference 25/PR/0953.
Full Scans
Free MRI Scans
Two comprehensive Open MRI assessments at our Lincolnshire centre to precisely monitor your recovery trajectory.
Tech Access
Exclusive Wearables
Immediate access to advanced semiconductor garment technology, available only to participants of this programme.
Drug/Invasives
Non-Invasive Protocol
A risk-managed study approach with zero surgery, zero injections, and no pharmaceutical intervention required.
Evidence Base
Pioneer Future Care
Your participation helps validate new regenerative pathways for active individuals worldwide.
Ready to contribute to Achilles Research?
*While individual benefit cannot be guaranteed, participation offers early access to a promising, low-risk approach under a formal research protocol.
Study Protocol
Your 24-Week Journey
A structured, low-burden clinical pathway designed to monitor your progress with precision while fitting seamlessly into your daily routine.
Enrollment & Baseline
Initial clinical assessment and your 1st scan at our specialist Sleaford Open MRI Centre to establish baseline data.
Active Therapeutic Phase
Daily wear of the provided semiconductor garments. This phase is designed for your comfort, requiring only brief weekly online check-ins.
Final Review & Validation
Completion of the study with a final clinical review and your 2nd MRI scan to document objective tendon recovery.
Total commitment: Only 2 clinic visits over 6 months.
*All imaging data is reviewed by consultant radiologists as part of the research protocol.
Ready to contribute to Achilles Research?
*While individual benefit cannot be guaranteed, participation offers early access to a promising, low-risk approach under a formal research protocol.
Why Take Part in Our Research?
Your participation bridges the gap between today’s clinical challenges and tomorrow’s non-invasive solutions. By joining, you become a vital part of an evidence-led journey to redefine tendon care.
Participation is entirely voluntary. All assessments and interventions are conducted under a formally approved UK research protocol.
Approving body
Health Research Authority (HRA)
REC reference
25/PR/0953
Pioneer Global Science
Directly contribute to innovative musculoskeletal research that helps clinicians worldwide understand and treat chronic tendon conditions more effectively.
Gain Clinical Clarity
Receive detailed insights into your own tendon health through high-resolution imaging and specialist assessments at no cost to you.
Shape Future Standards
Support the validation of drug-free, non-invasive treatments, reducing the global reliance on surgery and long-term medication.
Effortless Lifestyle Fit
Access advanced wearable technology designed to integrate seamlessly with your daily routine, requiring minimal clinical visits.
Ready to contribute to Achilles Research?
*While individual benefit cannot be guaranteed, participation offers early access to a promising, low-risk approach under a formal research protocol.
Understanding
Achilles Tendinopathy
Achilles tendinopathy affects the large tendon at the back of your ankle, impacting the foundational mechanics of movement. Whether from sudden strain or chronic overuse, it can make simple actions like standing or walking uphill significantly painful.
Morning Stiffness
Persistent rigidity in the ankle upon waking.
Localized Swelling
Visible thickening or inflammation of the tendon.
Activity Pain
Discomfort during uphill movement or running.
Mechanical Load
Pain when standing on tiptoes or weight-bearing.
The Aim of This Study
Our research focuses on validating a novel, non-compressive approach that addresses both Insertional and Non-Insertional pathologies without invasive measures.
Ready to contribute to Achilles Research?
*While individual benefit cannot be guaranteed, participation offers early access to a promising, low-risk approach under a formal research protocol.
Therapeutic Mechanism
How Will I Benefit from This Study?
This clinical programme evaluates a unique semiconductor-embedded garment system. By utilising a dual-phase protocol—Active Daytime and Restorative Night-time—the study aims to optimise the biological environment required for chronic tendon repair.
Daytime Ankle Sleeve
Engineered for daily mobility, the daytime sleeve provides structured compression while the integrated semiconductors facilitate micro-circulatory optimisation during movement.
- Kinetic Support
- Blood Flow Facilitation
Night Therapy Sock
Designed for sleep-cycle integration, this restorative garment focuses on lymphatic drainage and the modulation of inflammatory markers during the body's natural repair window.
- Lymphatic Decongestion
- Cytokine Regulation
Haemodynamic Support
The intervention is designed to boost localized blood and lymphatic flow, facilitating the efficient removal of metabolic waste and the delivery of essential repair nutrients.
Oedema Reduction
By modulating cytokine activity, the garments aim to reduce the persistent inflammation and swelling that characterizes chronic Achilles tendinopathy.
Tissue Restoration
The study tracks how non-invasive bio-textiles can support natural tendon recovery and muscular repair mechanisms without the need for pharmacological aid.
Objective Validation
Through high-resolution MRI, we monitor improvements in tendon vascularisation and structural thickness, providing objective clinical proof of your progress.
Ready to contribute to Achilles Research?
*While individual benefit cannot be guaranteed, participation offers early access to a promising, low-risk approach under a formal research protocol.
Bridging the Gap to
Non-Invasive Recovery
Traditional Achilles treatments—ranging from protracted exercise regimes to invasive surgeries—often yield mixed results or involve significant downtime. We are evaluating whether a science-led, drug-free approach can accelerate biological healing.
Traditional Pathways: Often slow, invasive, or unpredictable.
The MSK Innovation Pathway
Designed for accelerated healing and early return to active life.
Surgery & Injections
Wearable Intervention
The Participant Protocol
Clear steps designed to respect your daily routine.
Baseline Diagnostics
Attend a free Open MRI scan at our Lincolnshire centre to provide a detailed map of your tendon health.
Continuous Insights
Contribute vital data by sharing your symptom progression and activity levels via our secure research portal.
Daily Intervention
Integrate the study garments into your daily life, wearing them consistently throughout the evaluation period.
Clinical Guarantee: This study involves no medication and no injections.
Lincolnshire Open MRI Centre
How to Find Us
Clinical Address
London Rd, Silk Willoughby,Sleaford NG34 8NY,
United Kingdom
We are situated directly opposite Pennells - Four Seasons Garden Centre on London Road (A153).
Ready to contribute to Achilles Research?
*While individual benefit cannot be guaranteed, participation offers early access to a promising, low-risk approach under a formal research protocol.
Participant Responsibility
Your Commitment to
Clinical Excellence
Wearable Tech
Consistent daily use of the provided semiconductor garments as instructed by the clinical team.
Digital Logs
Completion of brief online questionnaires to track your functional progression and symptom changes.
Clinical Reviews
Attendance at all scheduled follow-up visits to ensure your safety and protocol compliance.
Advanced Imaging
Travel to our specialist Lincolnshire centre for two essential Open MRI scans (Start & Week 24).
Non-Invasive Study Assurance
Our priority is your comfort and safety. This programme is strictly evaluative and involves no physiological disruption.
Ready to contribute to Achilles Research?
Check EligibilityClinical
Governance
Upholding the highest standards of medical ethics and participant protection.
UK Regulatory Compliance
Health Research Authority Approval
This study has undergone formal UK regulatory review and has been approved by the Health Research Authority (HRA). The protocol is logged under REC reference 25/PR/0953, giving participants a specific approval identifier rather than a generic ethics claim.
Approving body
Health Research Authority (HRA)
REC reference
25/PR/0953
Participant Safety
Continuous clinical oversight to safeguard participant well-being throughout the study journey.
Data Protection
Full adherence to UK GDPR and Data Protection Acts, ensuring absolute participant confidentiality.
Ethical Conduct
Strict alignment with international Good Clinical Practice (GCP) and ethical conduct standards.
Transparency & Informed Consent
Before deciding to participate, you will receive full written information detailing every aspect of the research. Our clinical team is available to answer any questions, ensuring you have the clarity needed to make an informed decision.
DOCUMENTATION PROVIDEDReady to contribute to Achilles Research?
*While individual benefit cannot be guaranteed, participation offers early access to a promising, low-risk approach under a formal research protocol.
Research Partnership
The Power of Collaboration
This research is driven by a shared commitment to clinical excellence and technological innovation, bridging the gap between advanced bio-textiles and musculoskeletal science.
Innovation in Wearable Tech
Global leaders in semiconductor-embedded fabrics, Incrediwear provides the therapeutic infrastructure for our non-invasive recovery protocols.
Clinical Research Excellence
The clinical lead for the programme, MSK Doctors ensures every study meets the highest standards of evidence-led medicine and patient safety.
Research Mandate
Together, Incrediwear and MSK Doctors are committed to funding and developing regenerative treatment technologies that are entirely drug-free, non-surgical, and patient-centric.
United Kingdom • HRA Approved Research • REC 25/PR/0953